Regis Technologies
Richard Myer is an accomplished professional with extensive experience in business development and leadership within the pharmaceutical industry. Currently serving as Chief Business Development Officer at Regis Technologies and as a Board Member at LHN Pharmaceuticals, Richard also contributes to the editorial boards of Contract Pharma and Pharma Manufacturing. Previous roles include Vice President of Business Development at Tergus Pharma and Avara Pharmaceutical Services, and Strategic Business Director at Daniels Health. Richard holds an MBA and a BA from Purdue University, equipping him with a solid academic foundation for a career focused on business development, sales, marketing, licensing, and mergers and acquisitions.
Regis Technologies
Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.